Hide Studies Not Open or Pending
Condition(s):Recurrent Plasma Cell Myeloma; Refractory Plasma Cell MyelomaLast Updated:September 30, 2020Withdrawn
Condition(s):Relapsed and Refractory Multiple MyelomaLast Updated:June 8, 2018Terminated
Condition(s):Multiple MyelomaLast Updated:February 9, 2022Completed
Condition(s):Relapsed and Refractory Multiple MyelomaLast Updated:May 25, 2022Completed
Condition(s):Relapsed and/or Refractory Multiple MyelomaLast Updated:March 17, 2020Terminated
Condition(s):Multiple MyelomaLast Updated:October 20, 2022Completed
Condition(s):Relapsed or Refractory Multiple MyelomaLast Updated:February 1, 2022Recruiting
Condition(s):Multiple MyelomaLast Updated:January 27, 2023Terminated
Condition(s):Relapsed or Refractory Multiple MyelomaLast Updated:May 31, 2023Recruiting
Condition(s):Multiple MyelomaLast Updated:July 30, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.